These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6248999)

  • 1. [Inhibitors of crystallization and calcium nephrolithiasis].
    Baumann JM
    Ther Umsch; 1980 May; 37(5):363-72. PubMed ID: 6248999
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitors of renal lithiasis: historical course, current status and future perspectives].
    Grases F; Genestar C; Conte A
    Med Clin (Barc); 1988 Jan; 90(2):83-7. PubMed ID: 2831441
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Facilitators of calcium oxalate renal lithiasis: heterogeneous nucleation and aggregation capacity].
    Grases F; Genestar C; Conte A
    Med Clin (Barc); 1989 Jul; 93(5):189-94. PubMed ID: 2677550
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental studies on the effect of inhibitors of crystallization in the urine].
    Berg W; Börner RH
    Z Urol Nephrol; 1979 May; 72(5):383-90. PubMed ID: 225904
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nephrolithiasis--the mechanism and progression of nephrolithiasis].
    Yasui T; Okada A; Itoh Y; Tozawa K; Kohri K
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():618-22. PubMed ID: 16523965
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL
    Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of proteolytic enzymes, electrolytes and other factors on the crystallization of calcium oxalate in the urine].
    Börner RH; Brundig P; Mäurer F; Berg W; Baumann W
    Z Urol Nephrol; 1983 May; 76(5):327-31. PubMed ID: 6224367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary kidney stone inhibitors. What is the news?
    Dussol B; Berland Y
    Urol Int; 1998; 60(2):69-73. PubMed ID: 9563142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of recurrent calcium stones: diet versus drugs.
    Jaeger P
    Miner Electrolyte Metab; 1994; 20(6):410-3. PubMed ID: 7783704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamm-Horsfall glycoprotein and calcium nephrolithiasis.
    Hess B
    Miner Electrolyte Metab; 1994; 20(6):393-8. PubMed ID: 7783702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of 1-alpha-cholecalciferol in subjects treated for a prolonged time with diphosphonates for recurrent calcium nephrolithiasis].
    Jacobellis U; Salerno G; Ruotolo G
    Arch Esp Urol; 1984 Dec; 37 Suppl 1():577-81. PubMed ID: 6100036
    [No Abstract]   [Full Text] [Related]  

  • 15. Throw no stones: how to prevent calcium oxalate renal stones.
    Eichner ER
    Curr Sports Med Rep; 2010; 9(5):260-1. PubMed ID: 20827088
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperuricosuria and calcium nephrolithiasis.
    Coe FL; Parks JH
    Urol Clin North Am; 1981 Jun; 8(2):227-44. PubMed ID: 7268958
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is matrix theory still important today?].
    Börner RH; Schneider HJ
    Z Urol Nephrol; 1982 Jun; 75(6):463-8. PubMed ID: 6812310
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of calcium oxalate monohydrate crystal interactions with renal epithelial cells in the pathogenesis of nephrolithiasis: a review.
    Lieske JC; Hammes MS; Toback FG
    Scanning Microsc; 1996; 10(2):519-33; discussion 533-4. PubMed ID: 9813629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical studies in calcium oxalate stone formers, with special reference to the effects of thiazide treatment.
    Ahlstrand C
    Scand J Urol Nephrol Suppl; 1984; 81():1-93. PubMed ID: 6387895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.